CXCL5 and diabetes mellitus: Given the major role of EPCs and endothelial cells in angiogenesis, our findings support the direct contribution of CXCL5 inhibition to improve angiogenesis and wound healing in in vivo DM and these beneficial effects might be resulting from its angiogenic and anti-inflammatory abilities.